PADI2 is significantly associated with rheumatoid arthritis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chang, Xiaotian ^a   Xia, Yifang ^a   Pan, Jihong ^b   Meng, Qingsong ^a   Zhao, Yan ^b   Yan, Xinfeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ARGININE DEIMINASE; PROTEIN PADI2; UNCLASSIFIED DRUG; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OSTEOARTHRITIS; PADI2 GENE; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HUMANS; HYDROLASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNOVIAL MEMBRANE;

EID: 84891922699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081259     Document Type: Article

References (47)

1. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT (2007) Anticitrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts. Crit Rev Clin Lab Sci 44:339-363. (Pubitemid 46897707)
2. Sebbag M, Chapuy-Regaud S, Auger I, Petit-Texeira E, Clavel C, et al. (2004) Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Joint Bone Spine 71:493-502. (Pubitemid 39626716)
3. Nijenhuis S, Zendman AJ, Vossenaar ER, Pruijn GJ, van Venrooij WJ (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350:17-34. (Pubitemid 39458243)
4. Peene I, De Rycke L, Baeten D, Hoffman I, Veys EM, et al. (2004) History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis. Int J Immunopathol Pharmacol 17:107-116.
5. Kuna AT (2012) Mutated citrullinated vimentin antibodies in rheumatoid arthritis. Clin Chim Acta 413:66-73.
6. Suzuki A, Yamada R, Yamamoto K (2007) Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann N Y Acad Sci 1108:323-339. (Pubitemid 47528745)
7. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, et al. (2007) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395-402.
8. Kang CP, Lee HS, Ju H, Cho H, Kang C, et al. (2006) A functional haplotype of PADI4 gene associated with increased rheumatoid arthritis susceptibility in. Arthritis Rheum 54:90-96. (Pubitemid 43122191)
9. Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester G, et al. (2006) Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther: R34.
10. Panati K, Pal S, Rao KV, Reddy VD (2012) Association of single nucleotide polymorphisms (SNPs) of PADI4 gene with rheumatoid arthritis (RA) in Indian population. Genes Genet Syst 87:191-196.
11. Abd-Allah SH, el-Shal AS, Shalaby SM, Pasha HF, Abou el-Saoud AM, et al. (2012) PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients. Joint Bone Spine 79:124-128.
12. Kochi Y, Thabet MM, Suzuki A, Okada Y, Daha NA, et al. (2011) PADI4 polymorphism predisposes male smokers to rheumatoid arthritis. Ann Rheum Dis: 512-515.
13. Chen R, Wei Y, Cai Q, Duan S, Ren D, et al. (2011) The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatol Int 31:1631-1634.
14. Burr ML, Naseem H, Hinks A, Eyre S, Gibbons LJ, et al. (2010) BIRAC Consortium; YEAR Consortium, Barton A. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis 69:666-670.
15. Hoppe B, Häupl T, Egerer K, Gruber R, Kiesewetter H, et al. (2009) Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. Ann Rheum Dis 68:898-903.
16. Nishimoto K, Ikari K, Mochizuki T, Tomatsu T, Toyama Y, et al. (2008) Lack of association between PADI4 and functional severity in Japanese rheumatoid arthritis patients. Ann Rheum Dis 67:431-432. (Pubitemid 351281288)
17. Takata Y, Inoue H, Sato A, Tsugawa K, Miyatake K, et al. (2008) Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 53:163-173.
18. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27:827-833. (Pubitemid 46906647)
19. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, et al. (2005) Replication of putative candidate-gene associations with rheumatoid arthritis in. 4, 000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77:1044-1060. (Pubitemid 41698524)
20. Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, et al. (2005) Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 52:3054-3057. (Pubitemid 41447085)
21. Martinez A, Valdivia A, Pascual-Salcedo D, Lamas JR, Fernández- Arquero M, et al (2005) PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 44:1263-1266. (Pubitemid 41487959)
22. Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, et al. (2005) Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies. Ann Rheum Dis 64:1316-1320. (Pubitemid 41206249)
23. Barton A, Bowes J, Eyre S, Symmons D, Worthington J, et al. (2005) Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis. Ann Rheum Dis 64:1311-1315. (Pubitemid 41206248)
24. Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, et al. (2005) A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 64:587-593. (Pubitemid 40469089)
25. Hoppe B, Heymann GA, Tolou F, Kiesewetter H, Doerner T, et al (2004) High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach. J Mol Med (Berl) 82:762-767. (Pubitemid 40022270)
26. Hou S, Gao GP, Zhang XJ, Sun L, Peng WJ, et al. (2013) PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 23:60.
27. Harney SM, Meisel C, Sims AM, Woon PY, Wordsworth BP, et al. (2005) Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology (Oxford) 44:869-872. (Pubitemid 41511180)
28. Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, et al. (2007) Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Ann N Y Acad Sci 1110:23-32. (Pubitemid 350042993)
29. Harris ML, Darrah E, Lam GK, Bartlett SJ, Giles JT, et al. (2008) Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 58:1958-1967. (Pubitemid 351988087)
30. Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, et al. (2004) Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63:373-381. (Pubitemid 38453302)
31. Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, et al. (2003) Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 48:2489-2500. (Pubitemid 37129426)
32. Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, et al. (2005) Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44:40-50. (Pubitemid 40124330)
33. Chang X, Zhao Y, Sun S, Zhang Y, Zhu Y (2009) The expression of PADI4 in synovium of rheumatoid arthritis. Rheumatol Int 29:1411-1416.
34. Too CL, Murad S, Dhaliwal JS, Larsson PT, Jiang X, et al. (2012) Polymorphisms in peptidylarginine deiminase (PADI) associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and metaanalysis. Arthritis Res Ther 14:R250.
35. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 39:10627-10635.
36. Arandjelovic S, McKenney KR, Leming SS, Mowen KA (2012) ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor. J Immunol 189:4112-4122.
37. Ferrari-Lacraz S, Sebbag M, Chicheportiche R, Foulquier C, Serre G, et al. (2012) Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes. Eur Cytokine Netw 23:36-44.
38. Calabrese R, Zampieri M, Mechelli R, Annibali V, Guastafierro T, et al. (2012) Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood. Mult Scler 18:299-304.
39. Lee HJ, Joo M, Abdolrasulnia R, Young DG, Choi I, et al. (2010) Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Biol Chem 285:39655-39662.
40. Nakayama-Hamada M, Suzuki A, Kubota K, Takazawa T, Ohsaka M, et al. (2005) Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun 327:192-200. (Pubitemid 40051370)
41. Bodnár N, Szekanecz Z, Prohászka Z, Kemény-Beke A, Némethné-Gyurcsik Z, et al. (2012) Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis. Joint Bone Spine 79:63-66.
42. Bay-Jensen AC, Karsdal MA, Vassiliadis E, Wichuk S, Marcher-Mikkelsen K, et al. (2013) Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. Arthritis Rheum 65:972-280.
43. Chen R, Wei Y, Cai Q, Duan S, Lin J, et al. (2010) PADI4 gene polymorphism is not associated with ankylosing spondylitis in Chinese Han population. Scand J Immunol 72:449-453.
44. The International HapMap Consortium (2003) The International HapMap Project. Nature 426:789-796.
45. The International HapMap Consortium (2004) Integrating ethics and science in the International HapMap Project. Nature Reviews Genetics 5:467-475.
46. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
47. Li Z, Zhang Z, He Z, Tang W, Li T, et al. (2009) A partition- ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 19:519-523.